PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 71 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,181,000 | -25.3% | 837,153 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $4,261,000 | +0.3% | 837,153 | -0.4% | 0.00% | 0.0% |
| Q3 2019 | $4,250,000 | -17.6% | 840,753 | +0.6% | 0.00% | 0.0% |
| Q2 2019 | $5,156,000 | +55.7% | 835,653 | +17.1% | 0.00% | +100.0% |
| Q1 2019 | $3,312,000 | +822.6% | 713,791 | +736.1% | 0.00% | – |
| Q4 2018 | $359,000 | +26.9% | 85,367 | +89.4% | 0.00% | – |
| Q3 2018 | $283,000 | -21.8% | 45,070 | 0.0% | 0.00% | – |
| Q2 2018 | $362,000 | +7.7% | 45,070 | 0.0% | 0.00% | – |
| Q1 2018 | $336,000 | +25.4% | 45,070 | 0.0% | 0.00% | – |
| Q4 2017 | $268,000 | -78.6% | 45,070 | -73.6% | 0.00% | -100.0% |
| Q3 2017 | $1,254,000 | +41.2% | 170,439 | +30.4% | 0.00% | – |
| Q2 2017 | $888,000 | +11.6% | 130,703 | +55.0% | 0.00% | – |
| Q1 2017 | $796,000 | +3.2% | 84,314 | -5.5% | 0.00% | – |
| Q4 2016 | $771,000 | -52.8% | 89,201 | -65.5% | 0.00% | -100.0% |
| Q3 2016 | $1,635,000 | -35.7% | 258,331 | -57.1% | 0.00% | 0.0% |
| Q2 2016 | $2,544,000 | -3.9% | 602,728 | -0.8% | 0.00% | -50.0% |
| Q1 2016 | $2,648,000 | -33.2% | 607,328 | -6.0% | 0.00% | 0.0% |
| Q4 2015 | $3,962,000 | +5.2% | 646,263 | -1.8% | 0.00% | 0.0% |
| Q3 2015 | $3,766,000 | -23.3% | 658,380 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $4,911,000 | +22.5% | 658,380 | -1.8% | 0.00% | 0.0% |
| Q1 2015 | $4,009,000 | -20.9% | 670,451 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $5,069,000 | +45.7% | 670,451 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $3,480,000 | +18.4% | 670,451 | -1.7% | 0.00% | 0.0% |
| Q2 2014 | $2,939,000 | +1.5% | 681,846 | -3.7% | 0.00% | 0.0% |
| Q1 2014 | $2,896,000 | -23.5% | 708,064 | -0.3% | 0.00% | -33.3% |
| Q4 2013 | $3,786,000 | +6.1% | 710,364 | +0.2% | 0.00% | 0.0% |
| Q3 2013 | $3,567,000 | +25.3% | 709,203 | +11.1% | 0.00% | 0.0% |
| Q2 2013 | $2,847,000 | – | 638,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|